Thermo Fisher Scientific (TMO) and South Korea-based Celltrion Inc

Thermo Fisher (TMO) and South Korea''s Celltrion are competing for Baxter''s (BAX) Biopharma Solutions unit in a sale that could value the business at more than $4 billion.Private…

By Anirban Sen and David Carnevali (Reuters) -U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea’s Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc, according to people familiar with the matter.

U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea''s Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc, according to people familiar with the matter.

U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea’s Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc, according to people familiar with the matter. The divestment, which the sources said could fetch more than $4 billion, would help Baxter pay down debt […]

Baxter International Inc. (BAX) shares closed 0.8% lower than its previous 52 week low, giving the company a market cap of $20B. The stock is currently down 21.1% year-to-date, down 52.6% over the past 12 months, and down 35.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 2.0%. Trading Activity Trading volume this week was 31.3% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1834.6% The company's stock price performance over the past 12 months lags the peer average by 1330.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Baxter International Inc. (BAX) shares closed today at 1.8% above its 52 week low of $38.31, giving the company a market cap of $20B. The stock is currently down 21.1% year-to-date, down 52.6% over the past 12 months, and down 35.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 2.0%. Trading Activity Trading volume this week was 31.4% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1834.6% The company's stock price performance over the past 12 months lags the peer average by 1330.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Bodybuilding dietitian Holly Baxter said high-protein foods like yogurt can help with building muscle. She said the most successful diets are ones you can stay consistent with in the long term. Her dieting strategy includes room for treats like ice cream, so she can still enjoy food. You don''t have to live on chicken and rice or take expensive supplements to build muscle, according to a pro bodybuilder and dietitian. Holly Baxter, an international award-winning physique athlete, said she''s learned from personal and professional experience that the best diet for a strong, lean physique is one you can stick to long-term. "Find something that works for your preferences. It''s not super sexy or glamorous, but often people are looking for shortcuts that just aren''t sustainable," she told Insider. Baxter shared some of her favorite ways to get enough protein for a strong, muscular physique while eating real foods she enjoys. In total, she said she gets about 130 to 140 grams of protein per day, about the middle of the recommended range (about 1 – 1.3 grams per pound of lean body weight each day).

Baxter International Inc. (NYSE:BAX) traded at $39.71 at close of the session on Monday, 03/06/23, made a downward move of -0.58% on its previous day’s price. Looking at the stock we see that its previous close was $39.94 with the day’s price range being $39.70 – $40.15. In terms of its 52-week price range, BAX … Baxter International Inc.’s (NYSE:BAX) Stock Is Down -0.58%, But Is It Capable Of A Rally? Read More »

Baxter International Inc. (BAX) shares closed today at 1.8% above its 52 week low of $38.31, giving the company a market cap of $20B. The stock is currently down 21.1% year-to-date, down 52.6% over the past 12 months, and down 35.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 2.0%. Trading Activity Trading volume this week was 38.4% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1834.6% The company's stock price performance over the past 12 months lags the peer average by 1330.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Over the past three months, shares of Baxter Intl Inc. (NYSE: BAX ) decreased by 24.16%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials. One key aspect of a companies financials is its debt, but before we understand the importance of debt, let''s look at how much debt Baxter Intl has. Baxter Intl Debt According to the Baxter Intl''s most recent financial statement as reported on February 9, 2023, total debt is at $16.64 billion, with $15.23 billion in long-term debt and $1.40 billion in current debt. Adjusting for $1.72 billion in cash-equivalents, the company has a net debt of $14.92 billion. Let''s define some of the terms we used in … Full story available on Benzinga.com

(BAX) Constructed a change of -0.03% (Loss, ↓) in a total of its share price and finished it’s trading at 39.81. On 28 February 2023, Baxter International Inc., belongs to Healthcare sector … The post Morning Stocks to Keep Your Eyes on: Baxter International Inc. (NYSE:BAX) encountered the -0.03% below recently -0.03% appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Wondrous stocks: Comcast Corporation (NASDAQ:CMCSA -0.84%), Baxter International Inc. (NYSE:BAX -1.22%) appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enthralling stocks: Assertio Holdings, Inc. (NASDAQ:ASRT 3.28%), Baxter International Inc. (NYSE:BAX 0.76%) appeared first on Stocks Equity .

Wednesday marks the last chance for investors to receive the next dividend payout from Baxter Intl (NYSE: BAX ). What''s Happening The company announced on Tuesday that it would pay shareholders a quarterly dividend of 29 cents per share. On Thursday, Baxter Intl will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other … Full story available on Benzinga.com

Related Stocks: PYPL , GPN , BSX , BAX , COP ,

The BAXTER FOR CONGRESS successfully filed their F3T TERMINATION REPORT with the coverage period of 01/01/2023 to 02/17/2023 and a confirmation ID of FEC-1689540 *********CommitteeId: C00783720 | FilingId: 1689540 | FormType: F3T | CoverageFrom: 01/01/2023 | CoverageThrough: 02/17/2023 | ReportType: TERMINATION REPORT*********

New York, Global Drug Delivery Systems Market report from Global Insight Services is the single authoritative source of intelligence on Drug Delivery Systems Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine

Related Stocks: SCHZ , SCHX , TMO , AGG , BAX ,

Baxter (NYSE:BAX) declares $0.29/share quarterly dividend, in line with previous.Forward yield 2.91%.Payable April 3; for shareholders of record Feb. 24; ex-div Feb.

Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 3, 2023, to shareholders of record as of February 24, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of patients,

Baxter International Inc. (NYSE:BAX) traded at $40.31 at last check on Monday, February 13, made a downward move of -1.55% on its previous day’s price. Looking at the stock we see that its previous close was $40.95 and the beta (5Y monthly) reads 0.55 with the day’s price range being $39.87 – $41.59. In terms … Why Has Baxter International Inc. (NYSE: BAX) Declined So Much? Read More »

During the last session, Baxter International Inc. (NYSE:BAX)’s traded shares were 12.3 million, with the beta value of the company hitting 0.55. At the end of the trading day, the stock’s price was $40.95, reflecting an intraday gain of 2.02% or $0.81. The 52-week high for the BAX share is $89.24, that puts it down … Baxter International Inc. (NYSE: BAX) Declined -9.88% Over The Last Month – Are There Ways To Succeed From This Decline? Read More »

Macroeconomic woes were taking a toll on the medical tech company.

In the current trading session, Baxter International Inc.’s (BAX) stock is trading at the price of $41.06, a gain of 2.30% over last night’s close. So, the stock is trading at a price that is -53.98% less than its 52-week high of $89.24 and 6.44% better than its 52-week low of $38.58. Based on the […]

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Traders Recap: iQIYI, Inc. (NASDAQ:IQ 0.26%), Baxter International Inc. (NYSE:BAX 2.27%) appeared first on Stocks Equity .

According to Benzinga Pro, during Q4, Baxter International (NYSE: BAX ) earned $185.00 million, a 106.31% increase from the preceding quarter. Baxter International also posted a total of $3.89 billion in sales, a 3.02% increase since Q3. Baxter International collected $3.77 billion in revenue during Q3, but reported earnings showed a $2.93 billion loss. Why Is ROCE Significant? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of … Full story available on Benzinga.com

https://www.investing.com/news/pro/baxter-international-pt-lowered-to-52-at-keybanc-432SI-3000161

https://www.investing.com/news/pro/baxter-international-pt-lowered-to-45-at-stifel-432SI-3000043

AFRM and BAX dropped on earnings news. CSII jumped nearly 50% after reaching a deal to be acquired. HIMS soared to a 52-week high on an analyst upgrade.

It was not a good morning for Baxter International (NYSE:BAX) after its earnings report emerged. This healthcare stock that focuses on kidney disea…

Baxter International Inc. (NYSE:NYSE:BAX) Q4 2022 Earnings Conference Call February 9, 2023 8:30 AM ETCompany ParticipantsClare Trachtman - Vice President of Investor RelationsJosé Almeida…

Investors were disappointed by the medtech company''s Q4 update.

The company makes renal and hospital products

Baxter International Inc (NYSE: BAX) posted Q4 revenue of $3.89 billion , which beat the consensus of $3.77 billion, up 11% Y/Y on a reported basis, 17% on a constant currency, and 2% on an operational basis. Adjusted EPS of $0.88 came in below the consensus of $0.94. Advanced Surgery and Clinical Nutrition delivered mid-to-high single-digit growth at constant currency rates, reflecting solid demand across both … Full story available on Benzinga.com

Baxter International (BAX) lost ~8% pre-market Thursday after issuing its first quarter and full year 2023 guidance below expectations citing macro pressures

Baxter (BAX) is scheduled to announce Q4 earnings results on Thursday, February 9th, before market open.The consensus EPS Estimate is $0.94 (-9.6% Y/Y) and the consensus Revenue Estimate is…

https://www.investing.com/news/pro/baxter-international-pt-lowered-to-60-at-keybanc-432SI-2995702

Health Care sector has been a big loser in 2023 after last year''s relative rally. Baxter International follows up some disappointing results from other sector names. Read more here.

Miromatrix Medical (MIRO) announced Wednesday that Baxter (BAX) has partnered with it to develop a new liver therapy comprising its single-use bioengineered liver. Read the full story here.

EDEN PRAIRIE, Minn. and DEERFIELD, Ill., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO) and Baxter International Inc. (NYSE:BAX) today announced a collaborative research agreement to help support additional treatment options for patients with acute liver failure (ALF) in need of organ support therapies. As part of the collaboration, Miromatrix has created a new liver therapy called miroliver ELAP that combines a Miromatrix single-use bioengineered liver with Baxter’s PrisMax system. Miromatrix submitted an Investigational New Drug (IND) application for miroliver ELAP to the U.S. Food and Drug Administration (FDA) in November 2022, which appears to be the first IND for a bioengineered organ. Miromatrix intends to commence a Phase I clinical trial using miroliver ELAP to treat patients suffering from ALF, following FDA’s decision that the trial may proceed. Baxter is both a collaborator and shareholder of Miromatrix.

Related Stocks: SBUX , BAX , EW , MSFT , DE ,

2022 was a tough year for most global equities markets. One notable exception was Latin America. The iShares Latin America 40 ETF (NYSEARCA: ILF ) rose nearly 10% for the year compared with an 18% decline in the SPDR S&P 500 ETF (NYSEARCA: SPY ). With some strategists forecasting 2023 will be another strong year for the region, today we’ll consider three of the best South American stocks for investors to buy. Christopher Baxter, an investment strategist at Morgan Stanley Wealth Management , recently released a report on the investment opportunities in Latin America . According to Baxter, there are several factors that will work in the region’s favor in the year ahead, including moderating inflation and attractive stock valuations. You don’t have to twist my arm to get me excited about the best South American stocks. As far back as 2012, I’ve been a big believer in the region . There have been many ups and downs since then, but also plenty of opportunities in the grand scheme of things.

Baxter International Inc. (NYSE:BAX) has a beta value of 0.57 and has seen 4.43 million shares traded in the last trading session. The company, currently valued at $22.52B, closed the last trade at $44.91 per share which meant it lost -$0.23 on the day or -0.51% during that session. The BAX stock price is -99.73% … Baxter International Inc. (BAX) Falls -0.51%, Causing Bears To Lose Read More »